Seborrhoeic dermatitis and sebopsoriasis developing in patients on dupilumab: Two case reports

Abstract

Abstract Cutaneous adverse events to dupilumab can be varied; this necessitates keeping a broad differential diagnosis to identify seemingly paradoxical reactions. It may be possible to treat the adverse event concurrently without stopping dupilumab.

Keywords

• adverse event
• dupilumab
• sebopsoriasis
• seborrhoeic dermatitis